In a nutshell This report summarized important updates that have been made to the National Comprehensive Cancer Network’s guidelines for the use of systemic therapy in the treatment of breast cancer. Some background The National Comprehensive Cancer Network (NCCN) is a group of 26 of the world's leading cancer centers that...
Read More
In a nutshell This analysis provides recommendations on the correct use of biomarkers to guide decisions on systemic therapy for metastatic breast cancer. The article concluded that it is important that the medical community continue to carry out high-quality biomarker research for women with advanced breast cancer. Some background To help doctors...
Read More
In a nutshell In this analysis, the European Organization for Research and Treatment of Cancer (EORTC) and the International Society of Geriatric Oncology (SIOG) updated recommendations for treating elderly patients with non-small-cell lung cancer (NSCLC). Some background The average age of patients diagnosed with NSCLC is 71 years old. This is...
Read More
In a nutshell This review summarized guidelines for the active surveillance of localized prostate cancer. The authors reported that active surveillance is a suitable strategy for the management of most low-risk prostate cancers provided appropriate monitoring protocols are followed. Some background Active surveillance refers to actively monitoring...
Read More
In a nutshell This review was conducted in an effort to update current guidelines for the prevention of nausea and vomiting in patients receiving chemotherapy. According to this update by the American Society of Clinical Oncology, all patients who receive highly emetogenic chemotherapies (treatments known to cause nausea and vomiting) should be...
Read More
In a nutshell This review was conducted in an effort to update current guidelines for the prevention of nausea and vomiting in patients receiving chemotherapy. According to this update by the American Society of Clinical Oncology, all patients who receive highly emetogenic chemotherapies (treatments known to cause nausea and vomiting) should be...
Read More
In a nutshell This review was conducted in an effort to update current guidelines for the prevention of nausea and vomiting in patients receiving chemotherapy. According to this update by the American Society of Clinical Oncology, all patients who receive highly emetogenic chemotherapies (treatments known to cause nausea and vomiting) should be...
Read More
In a nutshell This review was conducted in an effort to update current guidelines for the prevention of nausea and vomiting in patients receiving chemotherapy. According to this update by the American Society of Clinical Oncology, all patients who receive highly emetogenic chemotherapies (treatments known to cause nausea and vomiting) should be...
Read More
In a nutshell This review was conducted in an effort to update current guidelines for the prevention of nausea and vomiting in patients receiving chemotherapy. According to this update by the American Society of Clinical Oncology, all patients who receive highly emetogenic chemotherapies (treatments known to cause nausea and vomiting) should be...
Read More
In a nutshell This summary outlined the current recommendations for the management of type 2 diabetes. The authors concluded that the management strategies available differ for each individual. Some background Type 2 diabetes (T2D) is a progressive disease. While it may be controlled at first with lifestyle changes, such as diet and exercise,...
Read More
In a nutshell In this study, the authors discussed several evidence-based treatment guidelines for rheumatoid arthritis (RA). These guidelines were meant to serve as a tool for clinicians to decide treatment options for patients. Some background In RA, the immune system begins attacking healthy tissues the way it normally attacks...
Read More
In a nutshell These guidelines offer recommendations for the long-term follow-up and care of breast cancer survivors. Some background The 5-year survival rate for breast cancer is currently close to 90%. Thanks to early diagnosis and care, an ever-increasing number of patients are surviving for long periods of time following treatment. Therefore,...
Read More
